TP53 and osteosarcoma: In fixed-effect model, a statistically significant correlation between the TP53 rs1042522 polymorphism and osteosarcoma risk was observed (GG versus GC/CC: OR = 1.569, 95% CI 1.196–2.057, P=0.001).